Clicky

Cryo-Cell International, Inc.(CCEL)

Description: Cryo-Cell International, Inc. is the world’s first private cord blood bank. More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their baby’s cord blood and cord tissue stem cells. In addition to its private bank, Cryo-Cell International has a public banking program in partnership with Duke University. Cryo-Cell’s public bank has provided cord blood for more than 600 transplantations and operates cord blood donation sites across the U.S in prominent hospitals such as Cedars–Sinai Hospital in Los Angeles and Baptist Hospital in Miami. Cryo-Cell’s facility is FDA registered, cGMP-/cGTP-compliant and licensed in all states requiring licensure. Besides being AABB accredited as a cord blood facility, Cryo-Cell was also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. Cryo-Cell owns the exclusive rights ‎to PrepaCyte-CB, the industry’s most advanced cord blood processing technology.


Keywords: Biology Stem Cell Blood FDA Private Bank Cord Blood Childbirth Cord Blood Bank Cryo Cryo Save

Home Page: www.cryo-cell.com

CCEL Technical Analysis

700 Brooker Creek Boulevard
Oldsmar, FL 34677
United States
Phone: 813 749 2100


Officers

Name Title
Mr. David I. Portnoy Chairman & Co-CEO
Mr. Mark L. Portnoy Co-CEO & Director
Ms. Jill M. Taymans CFO & VP of Fin.
Mr. Oleg Mikulinsky Chief Information Officer
Dr. Joanne Kurtzberg M.D. Medical Director and Member of Medical & Scientific Advisory Board

Exchange: NYSE MKT

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 29.125
Price-to-Book MRQ: 9.7236
Price-to-Sales TTM: 1.2029
IPO Date: 1997-01-21
Fiscal Year End: November
Full Time Employees: 83
Back to stocks